This week, the Kalamazoo Gazette published an op-ed on how we can accelerate the discovery, development and delivery of treatments and cures for patients written by Stephen Rapundalo, President and CEO of MichBio, and BIO’s Jim Greenwood.
The op-ed highlights the focus of roundtable discussions being held across the country as part of the 21st Century Cures Initiative. The U.S. House of Representatives’ Energy and Commerce Committee launched the initiative – led by Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO) – and hosted a roundtable in Kalamazoo earlier this week.
The authors urge continued investment in scientific research, development and adoption of more efficient approaches to drug development, collaborations and partnerships to support research and development, regulatory agencies’ efforts to keep pace with science, transfer of new technology, policies that protect intellectual property, and reimbursement policies to ensure continued innovation and access to medicines for patients.
‘A forward-thinking innovation ecosystem will ensure that patients continue to receive the benefits of new therapies and new cures as we move further into the 21st Century,’ write Rapundalo and Greenwood.
The full op-ed can be accessed here.